Loading viewer...
earnings
Format: PDF earnings
Moderna presented first quarter 2024 financial results and business update on May 2, 2024, including RSV vaccine commercialization plans, 2024 financial guidance, and pipeline milestones. The earnings presentation outlined anticipated product sales, competitive positioning, and clinical development progress for multiple mRNA programs.
earnings
17 Pages
Ahlstrom Holding 3 Oy
Shankara Q1 FY2024 Results Investor Presentation August 2023
earningsearnings
24 Pages
Shankara Building Materials
Compass Minerals Q3 2016 Earnings Update Business Review
earningsearnings
17 Pages
Compass Minerals International
JLL Q1 2023 Earnings Presentation
earningsearnings
26 Pages
Jones Lang LaSalle